215
Views
8
CrossRef citations to date
0
Altmetric
Research Articles

Toward a better understanding of the interaction between somatostatin receptor 2 and its ligands: a structural characterization study using molecular dynamics and conceptual density functional theory

, , , &
Pages 3081-3102 | Received 13 May 2018, Accepted 26 Jul 2018, Published online: 17 Nov 2018

References

  • Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990). Basic local alignment search tool. Journal of Molecular Biology, 215(3), 403–410.
  • Altschul, S. F., Madden, T. L., Schäffer, A. A., Zhang, J., Zhang, Z., Miller, W., & Lipman, D. J. (1997). Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Research, 25(17), 3389–3402.
  • Becke, A. (1988). Density-functional exchange-energy approximation with correct asymptotic behavior. Physical Review A, 38(6), 3098–3100.
  • Becke, A. (1993). A new mixing of Hartree–Fock and local density‐functional theories. The Journal of Chemical Physics, 98(2), 1372–1377.
  • Benkert, P., Tosatto, S., & Schomburg, D. (2008). QMEAN: A comprehensive scoring function for model quality assessment. Proteins: Structure, Function, and Bioinformatics, 71(1), 261–277.
  • Berman, H. M., Battistuz, T., Bhat, T. N., Bluhm, W. F., Bourne, P. E., Burkhardt, K., … Zardecki, C. (2002). The Protein Data Bank. Acta Crystallographica. Section D, Biological Crystallography, 58(Pt 6 No. 1), 899–907.
  • Bostan, R., Varvara, S., Găină, L., & Mureşan, L. (2012). Evaluation of some phenothiazine derivatives as corrosion inhibitors for bronze in weakly acidic solution. Corrosion Science, 63, 275–286.
  • Bousquet, C., Guillermet-Guibert, J., Saint-Laurent, N., Archer-Lahlou, E., Lopez, F., Fanjul, M., … Susini, C. (2006). Direct binding of p85 to sst2 somatostatin receptor reveals a novel mechanism for inhibiting PI3K pathway. The EMBO Journal, 25(17), 3943–3954.
  • Bruns, C., Raulf, F., Hoyer, D., Schloos, J., Lübbert, H., & Weckbecker, G. (1996). Binding properties of somatostatin receptor subtypes. Metabolism, 45, 17–20.
  • Burgus, R., Ling, N., Butcher, M., & Guillemin, R. (1973). Primary structure of somatostatin, a hypothalamic peptide that inhibits the secretion of pituitary growth hormone. Proceedings of the National Academy of Sciences, 70(3), 684–688.
  • Caron, P. (1997). Three year follow-up of acromegalic patients treated with intramuscular slow-release lanreotide. Journal of Clinical Endocrinology & Metabolism, 82(1), 18–22.
  • Caron, P., Beckers, A., Cullen, D. R., Goth, M. I., Gutt, B., Laurberg, P., … Zgliczynski, W. (2002). Efficacy of the new long-acting formulation of lanreotide (lanreotide autogel) in the management of acromegaly. The Journal of Clinical Endocrinology and Metabolism, 87(1), 99–104.
  • Clark, M., Cramer, R., & Van Opdenbosch, N. (1989). Validation of the general purpose tripos 5.2 force field. Journal of Computational Chemistry, 10(8), 982–1012.
  • Colovos, C., & Yeates, T. (1993). Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Science, 2(9), 1511–1519.
  • Comeau, S., Gatchell, D., Vajda, S., & Camacho, C. (2004). ClusPro: A fully automated algorithm for protein-protein docking. Nucleic Acids Research, 32(Web Server), W96–W99.
  • Contour-Galcéra, M., Sidhu, A., Plas, P., & Roubert, P. (2005). 3-Thio-1,2,4-triazoles, novel somatostatin sst2/sst5 agonists. Bioorganic & Medicinal Chemistry Letters, 15(15), 3555–3559.
  • Cramer, R., Patterson, D., & Bunce, J. (1988). ChemInform abstract: Comparative molecular field analysis (CoMFA). Part 1. Effect of shape on binding of steroids to carrier proteins. ChemInform, 19(51), 5959–5967
  • Curry, D., & Bennett, L. (1976). Does somatostatin inhibition of insulin secretion involve two mechanisms of action? Proceedings of the National Academy of Sciences, 73(1), 248–251.
  • Domingo, L., Ríos-Gutiérrez, M., & Pérez, P. (2016). Applications of the conceptual density functional theory indices to organic chemistry reactivity. Molecules, 21(6), 748.
  • Durham, E., Dorr, B., Woetzel, N., Staritzbichler, R., & Meiler, J. (2009). Solvent accessible surface area approximations for rapid and accurate protein structure prediction. Journal of Molecular Modeling, 15(9), 1093–1108.
  • Epelbaum, J. (1995). Molecular aspects of multiple somatostatin receptor functions. Pharmacological Research, 31, 164.
  • Esposito, E., Tobi, D., & Madura, J. (2006). Comparative protein modeling. Reviews in Computational Chemistry, 22, 57–167.
  • Eswar, N., Webb, B., Marti-Renom, M. A., Madhusudhan, M. S., Eramian, D., Shen, M-y., … Sali, A. (2006). Comparative protein structure modeling using modeller. Current Protocols in Bioinformatics, 15(1), 5.6.1–5.6.30.
  • Fani, M., Del Pozzo, L., Abiraj, K., Mansi, R., Tamma, M. L., Cescato, R., … Maecke, H. R. (2011). PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: The chelate makes the difference. Journal of Nuclear Medicine, 52(7), 1110–1118.
  • Fazil, M., Kumar, S., Subbarao, N., Pandey, H., & Singh, D. (2010). Homology modelling of a sensor histidine kinase from Aeromonas hydrophila. Journal of Molecular Modeling, 16(5), 1003–1009.
  • Frisch, M., Trucks, G., Schlegel, H., Scuseria, G., Robb, M., Cheeseman, J., …., Fox, D. (2016). Gaussian 16 (Version Revision B.01) [Linux]. Wallingford CT: Gaussian, Inc.
  • Fukui, K. (1982). The role of frontier orbitals in chemical reactions (Nobel lecture). Angewandte Chemie International Edition in English, 21(11), 801–809.
  • Gasteiger, J., & Marsili, M. (1980). Iterative partial equalization of orbital electronegativity—A rapid access to atomic charges. Tetrahedron, 36(22), 3219–3228.
  • Geerlings, P., De Proft, F., & Langenaeker, W. (2003). Conceptual density functional theory. Cheminform, 103(5), 1793–1873.
  • Han, L., Yang, D., & Kundra, V. (2007). Signaling can be uncoupled from imaging of the somatostatin receptor type 2. Molecular Imaging, 6(6), 427–437.
  • Hohenberg, P., & Kohn, W. (1964). Inhomogeneous electron gas. Physical Review, 136(3B), B864–B871.
  • Hoyer, D., Bell, G. I., Berelowitz, M., Epelbaum, J., Feniuk, W., Humphrey, P. P. A., … Reisine, T. (1995). Classification and nomenclature of somatostatin receptors. Trends in Pharmacological Sciences, 16(3), 86–88.
  • Hugues, J., Epelbaum, J., Voirol, M., Sebaoun, J., Kordon, C., & Enjalbert, A. (1986). Involvement of endogenous somatostatin in the regulation of thyrotroph secretion during acute and chronic changes in diet. Neuroendocrinology, 43(3), 435–439.
  • Iversen, J. (1974). Inhibition of pancreatic glucagon release by somatostatin: In vitro. Scandinavian Journal of Clinical and Laboratory Investigation, 33(2), 125–129.
  • Jain, A. (1996). Scoring noncovalent protein-ligand interactions: A continuous differentiable function tuned to compute binding affinities. Journal of Computer-Aided Molecular Design, 10(5), 427–440.
  • Jain, A. (2003). Surflex: Fully automatic flexible molecular docking using a molecular similarity-based search engine. Journal of Medicinal Chemistry, 46(4), 499–511.
  • Jain, A. (2006). Scoring functions for protein-ligand docking. Current Protein & Peptide Science, 7(5), 407–420.
  • Kong, H., Raynor, K., Yasuda, K., Bell, G., & Reisine, T. (1993). Mutation of an aspartate at residue 89 in somatostatin receptor subtype 2 prevents Na + regulation of agonist binding but does not alter receptor-G protein association. Molecular Pharmacology, 44(2), 380–384.
  • Kothandan, G., & Cho, S. (2013). Homology modeling of GPR18 receptor, an orphan G-protein-coupled receptor. Journal of the Chosun Natural Science, 6(1), 16–20.
  • Kozakov, D., Beglov, D., Bohnuud, T., Mottarella, S., Xia, B., Hall, D., & Vajda, S. (2013). How good is automated protein docking? Proteins: Structure, Function, and Bioinformatics, 81(12), 2159–2166.
  • Kozakov, D., Brenke, R., Comeau, S., & Vajda, S. (2006). PIPER: An FFT-based protein docking program with pairwise potentials. Proteins: Structure, Function, and Bioinformatics, 65(2), 392–406.
  • Kozakov, D., Hall, D. R., Xia, B., Porter, K. A., Padhorny, D., Yueh, C., … Vajda, S. (2017). The ClusPro web server for protein–protein docking. Nature Protocols, 12(2), 255–278.
  • Kuntal, B., Aparoy, P., & Reddanna, P. (2010). EasyModeller: A graphical interface to modeller. BMC Research Notes, 3(1), 226
  • Lamberts, S., van der Lely, A., de Herder, W., & Hofland, L. (1996). Octreotide. The New England Journal of Medicine, 334(4), 246–254.
  • Le Verche, V., Kaindl, A. M., Verney, C., Csaba, Z., Peineau, S., Olivier, P., … Dournaud, P. (2009). The somatostatin 2A receptor is enriched in migrating neurons during rat and human brain development and stimulates migration and axonal outgrowth. PLoS ONE, 4(5), e5509.
  • Lee, C., Yang, W., & Parr, R. (1988). Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Physical Review B, 37(2), 785–789.
  • Lensink, M., & Wodak, S. (2013). Docking, scoring, and affinity prediction in CAPRI. Proteins: Structure, Function, and Bioinformatics, 81(12), 2082–2095.
  • Lovell, S. C., Davis, I. W., Arendall, W. B., de Bakker, P. I. W., Word, J. M., Prisant, M. G., … Richardson, D. C. (2003). Structure validation by Cα geometry: ϕ,ψ and Cβ deviation. Proteins: Structure, Function, and Bioinformatics, 50(3), 437–450.
  • Lüthy, R., Bowie, J., & Eisenberg, D. (1992). Assessment of protein models with three-dimensional profiles. Nature, 356(6364), 83–85.
  • Mert, B., Erman Mert, M., Kardaş, G., & Yazıcı, B. (2011). Experimental and theoretical investigation of 3-amino-1,2,4-triazole-5-thiol as a corrosion inhibitor for carbon steel in HCl medium. Corrosion Science, 53(12), 4265–4272.
  • Nagarajan, S., Babu, S., & Madhavan, T. (2017). Theoretical analysis of somatostatin receptor 5 with antagonists and agonists for the treatment of neuroendocrine tumors. Molecular Diversity, 21(2), 367–384.
  • Nilsson, O., Kölby, L., Wängberg, B., Wigander, A., Billig, H., William-Olsson, L., … Ahlman, H. (1998). Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours. British Journal of Cancer, 77(4), 632–637.
  • Obiol-Pardo, C., & Rubio-Martinez, J. (2009). Homology modeling of human transketolase: Description of critical sites useful for drug design and study of the cofactor binding mode. Journal of Molecular Graphics and Modelling, 27(6), 723–734.
  • Oostenbrink, C., Villa, A., Mark, A., & Van Gunsteren, W. (2004). A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force-field parameter sets 53A5 and 53A6. Journal of Computational Chemistry, 25(13), 1656–1676.
  • Ösapay, G., & Ösapay, K. (1998). Therapeutic applications of somatostatin analogues. Expert Opinion on Therapeutic Patents, 8(7), 855–870.
  • Parry, J., Chen, R., Andrews, R., Lears, K., & Rogers, B. (2012). Identification of critical residues involved in ligand binding and G protein signaling in human somatostatin receptor subtype 2. Endocrinology, 153(6), 2747–2755.
  • Patel, Y., & Srikant, C. (1994). Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (HSSTR 1-5). Endocrinology, 135(6), 2814–2817.
  • Patel, Y., & Wheatley, T. (1983). In vivo and in vitro plasma disappearance and metabolism of somatostatin-28 and somatostatin-14 in the Rat*. Endocrinology, 112(1), 220–225.
  • Pearson, R. (1986). Absolute electronegativity and hardness correlated with molecular orbital theory. Proceedings of the National Academy of Sciences, 83(22), 8440–8441.
  • Pontius, J., Richelle, J., & Wodak, S. (1996). Deviations from standard atomic volumes as a quality measure for protein crystal structures. Journal of Molecular Biology, 264(1), 121–136.
  • Powell, M. (1964). An efficient method for finding the minimum of a function of several variables without calculating derivatives. The Computer Journal, 7(2), 155–162.
  • Raptis, S., Schlegel, W., Lehmann, E., Dollinger, H., & Zoupas, C. (1978). Effects of somatostatin on the exocrine pancreas and the release of duodenal hormones. Metabolism: clinical and Experimental, 27(9 Suppl. 1), 1321–1328.
  • Remke, M., Hering, E., Gerber, N. U., Kool, M., Sturm, D., Rickert, C. H., … Frühwald, M. C. (2013). Somatostatin receptor subtype 2 (sst2) is a potential prognostic marker and a therapeutic target in medulloblastoma. Child's Nervous System, 29(8), 1253–1262.
  • Reubi, J., Kvols, L., Krenning, E., & Lamberts, S. (1990). Distribution of somatostatin receptors in normal and tumor tissue. Metabolism: clinical and Experimental, 39(9 Suppl. 2), 78–81.
  • Rohrer, S. (1998). Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science, 282(5389), 737–740.
  • Schwartkop, C., Kreienkamp, H., & Richter, D. (2008). Agonist-independent internalization and activity of a C-terminally truncated somatostatin receptor subtype 2(δ349). Journal of Neurochemistry, 72(3), 1275–1282.
  • Shahlaei, M., Madadkar-Sobhani, A., Mahnam, K., Fassihi, A., Saghaie, L., & Mansourian, M. (2011). Homology modeling of human CCR5 and analysis of its binding properties through molecular docking and molecular dynamics simulation. Biochimica Et Biophysica Acta (BBA) - Biomembranes, 1808(3), 802–817.
  • Shimon, I., Taylor, J. E., Dong, J. Z., Bitonte, R. A., Kim, S., Morgan, B., … Melmed, S. (1997). Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation. Journal of Clinical Investigation, 99(4), 789–798.
  • Siehler, S., Seuwen, K., & Hoyer, D. (1998). [125I][Tyr3]octreotide labels human somatostatin sst2 and sst5 receptors. European Journal of Pharmacology, 348(2-3), 311–320.
  • Singh, T., Biswas, D., & Jayaram, B. (2011). AADS—An automated active site identification, docking, and scoring protocol for protein targets based on physicochemical descriptors. Journal of Chemical Information and Modeling, 51(10), 2515–2527.
  • Strnad, J., & Hadcock, J. (1995). Identification of a critical aspartate residue in transmembrane domain three necessary for the binding of somatostatin to the somatostatin receptor SSTR2. Biochemical and Biophysical Research Communications, 216(3), 913–921.
  • Taylor, J., Theveniau, M., Bashirzadeh, R., Reisine, T., & Eden, P. (1994). Detection of somatostatin receptor subtype 2 (SSTR2) in established tumors and tumor cell lines: Evidence for SSTR2 heterogeneity. Peptides, 15(7), 1229–1236.
  • Teijeiro, R., Rios, R., Costoya, J., Castro, R., Bello, J., Devesa, J., … Arce, V. (2002). Activation of human somatostatin receptor 2 promotes apoptosis through a mechanism that is independent from induction of p53. Cellular Physiology and Biochemistry, 12(1), 31–38.
  • Tichomirowa, M., Daly, A., & Beckers, A. (2005). Treatment of pituitary tumors: Somatostatin. Endocrine, 28(1), 93–100.
  • Tripos International (2010). Sybyl—X (Version 2.1) [Windows]. St. Louis, MO.
  • van Der Hoek, J., Lamberts, S., & Hofland, L. (2005). Role of somatostatin receptor subtypes in acromegaly. The Endocrinologist, 15(6), 377–383.
  • Vanetti, M., Vogt, G., & Höllt, V. (1993). The two isoforms of the mouse somatostatin receptor (mSSTR2A and mSSTR2B) differ m coupling efficiency to adenylate cyclase and in agonist-induced receptor desensitization. FEBS Letters, 331(3), 260–266.
  • Vieria Neto, L., Wildemberg, L. E., Colli, L. M., Kasuki, L., Marques, N. V., Moraes, A. B., … Gadelha, M. R. (2013). ZAC1 and SSTR2 are downregulated in non-functioning pituitary adenomas but not in somatotropinomas. PLoS ONE, 8(10), e77406
  • Viollet, C., Vaillend, C., Videau, C., Bluet-Pajot, M. T., Ungerer, A., L'héritier, A., … Epelbaum, J. (2000). Involvement of sst2 somatostatin receptor in locomotor, exploratory activity and emotional reactivity in mice. European Journal of Neuroscience, 12(10), 3761–3770.
  • Vyas, V., Ukawala, R., Chintha, C., & Ghate, M. (2012). Homology modeling a fast tool for drug discovery: Current perspectives. Indian Journal of Pharmaceutical Sciences, 74(1), 1.
  • Wiederstein, M., & Sippl, M. (2007). ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Research, 35(Web Server), W407–W410.
  • Wold, S. (1978). Cross-validatory estimation of the number of components in factor and principal components models. Technometrics, 20(4), 397.
  • Wold, S., Albano, C., Dunn, W., Edlund, U., Esbensen, K., Geladi, P., …., Sjöström, M. (1984). Multivariate data analysis in chemistry. Chemometrics, 138, 17–95.
  • Wu, B., Zhang, Y., Kong, J., Zhang, X., & Cheng, S. (2009). In silico predication of nuclear hormone receptors for organic pollutants by homology modeling and molecular docking. Toxicology Letters, 191(1), 69–73.
  • Xiang, Z. (2006). Advances in homology protein structure modeling. Current Protein & Peptide Science, 7(3), 217–227.
  • Yang, J., Yan, R., Roy, A., Xu, D., Poisson, J., & Zhang, Y. (2015). The I-TASSER suite: protein structure and function prediction. Nature Methods, 12(1), 7–8.
  • Yang, L., Berk, S. C., Rohrer, S. P., Mosley, R. T., Guo, L., Underwood, D. J., … Patchett, A. A. (1998). Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2. Proceedings of the National Academy of Sciences, 95(18), 10836–10841.
  • Zhan, C., Nichols, J., & Dixon, D. (2003). Ionization potential, electron affinity, electronegativity, hardness, and electron excitation energy: Molecular properties from density functional theory orbital energies. The Journal of Physical Chemistry A, 107(20), 4184–4195.
  • Zhou, C., Guo, L., Morriello, G., Pasternak, A., Pan, Y., Rohrer, S. P., … Yang, L. (2001). Nipecotic and iso-nipecotic amides as potent and selective somatostatin subtype-2 receptor agonists. Bioorganic & Medicinal Chemistry Letters, 11(3), 415–417.
  • Zitzer, H., Hönck, H., Bächner, D., Richter, D., & Kreienkamp, H. (1999). Somatostatin receptor interacting protein defines a novel family of multidomain proteins present in human and rodent brain. Journal of Biological Chemistry, 274(46), 32997–33001.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.